Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;47(19):e202400277.
doi: 10.1002/jssc.202400277.

High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan

Nguyen Minh Luan  1 , Vo Thi Kim Khuyen  1 , Nguyen Duc Tuan  1
Affiliations

High-Performance Liquid Chromatography-Tandem Mass Spectrometry Method Development and Validation for Simultaneous Determination of Seven Nitrosamine and Azidomethyl-Biphenyl-Tetrazole Impurities in Losartan

Nguyen Minh Luan et al. J Sep Sci. 2024 Oct.

Abstract

Nitrosamine-related impurities (N-nitrosomethylamino butyric acid [NMBA], N-nitrosodiethylamine [NDEA], N-nitrosodiisopropylamine [NDIPA], N-nitrosomethylphenylamine [NMPA], N-nitrosodibutylamine [NDBA], N-nitrosodimethylamine [NDMA], and N-nitrosoethylisopropylamine [NEIPA]) and 5-[4'-(azidomethyl)-[1,1'-biphenyl]-2-yl]-2H-tetrazole (AZBT) formed during the manufacture of sartan medicines have been classified into human mutagens and carcinogens after long-term treatment. The study developed a simple, economical but highly sensitive procedure for the simultaneous quantification of seven nitrosamines and AZBT impurities in sartan pharmaceuticals. After extraction with methanol (MeOH) 50%, the compounds were analyzed with a reversed-phase liquid chromatography-tandem mass spectroscopy with atmospheric-pressure chemical ionization (APCI) mode (APCI[+] for nitrosamines and APCI[-] for AZBT), selected reaction monitoring, C18 column, gradient elution with 0.1% formic acid in water and in MeOH, respectively. The validated procedure obtained high extraction efficiency (>90%), wide linear range (0.2-50.0 ng/mL NMBA, NDEA, NDIPA, NMPA, and NDBA; 0.5-50.0 ng/mL NDMA and NEIPA; 2.0-100 ng/mL AZBT), limit of quantification < 10% of the acceptance level, recovery range of 85%-115% with relative standard deviation < 15% and minimum matrix effects for all impurities. The procedure was applied to test 16 commercial losartan samples. As a result, eight samples contained AZBT within the current regulatory limits, but no nitrosamine impurities were detected in all samples.

Keywords: atmospheric‐pressure chemical ionization | azidomethyl‐biphenyl‐tetrazole | impurities | losartan | method validation | N‐nitrosamines.

PubMed Disclaimer

References

    1. P. N. Magee and J. M. Barnes, “The Production of Malignant Primary Hepatic Tumors in the Rat by Feeding Dimethylnitrosamine,” British Journal of Cancer 10 (1956): 114–122, https://doi.org/10.1038/bjc.1956.15.
    1. M. Iram, “From Valsartan to Ranitidine: The Story of Nitrosamines So Far,” Indian Journal of Pharmacy Practice 13, no. 1 (2019): 01–02, https://doi.org/10.5530/ijopp.13.1.1.
    1. US FDA, “FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan),” Accessed September 21, 2023, https://www.fda.gov/drugs/drug‐safety‐and‐availability/fda‐updates‐and‐p....
    1. European Medicine Agency, “EMA/369136/2020, Committee for Medicinal Products for Human Use (CHMP) Procedure under Article 5(3) of Regulation EC (No) 726/2004: Nitrosamine impurities in human medicinal products,” 2020.
    1. ICH Harmonized Guideline, “Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk. M7(R2)”. 2023.

Publication types

MeSH terms